Posts Tagged ‘Swiss Group’

Novartis Drug Combo Cuts Pancreatic Tumour Size

24th June 2009 by admin No Comments

A combination of two drugs from Novartis AG (NOVN.VX) cut the size of pancreatic neuroendocrine tumours in more than 80 percent of patients in a mid-stage study, the Swiss group said on Wednesday. Patients who received a once-daily pill Afinitor in combination with Sandostatin LAR had no progression in their disease for a median of [...]